MotivaImplants® MotivaImagine® Careers

Investors

Press Releases

Press Releases

July 29, 2021
Establishment Labs Reports Record Second Quarter 2021 Financial Results and Raises Full Year Guidance
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 29, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second
Read More
July 20, 2021
Establishment Labs Releases 2020 Corporate Social Responsibility Annual Review
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 20, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced publication of its 2020 Corporate Social Responsibility
Read More
July 16, 2021
Establishment Labs to Announce Second Quarter 2021 Financial Results on July 29
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 16, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2021
Read More
July 15, 2021
Establishment Labs Announces Appointment of Ann Custin and Bryan Slotkin to Board of Directors
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 15, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the appointment of Ann Custin and Bryan Slotkin to its
Read More
July 12, 2021
Establishment Labs Announces Departure of CFO and Appointment of Raj Denhoy as Interim CFO
Company also announces preliminary second quarter 2021 revenue of $31 million to $32 million SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 12, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and
Read More
June 23, 2021
Establishment Labs Breaks Ground on Third Facility, Preparing to Expand Capabilities in Manufacturing, R&D, and Medical Education
Facility will support Establishment Labs’ planned growth, including launches of Motiva® Flora® and of Motiva MIA® as well as geographic expansion into China and the United States . Builds on Establishment Labs’ world class manufacturing operations in Costa Rica ; annual capacity will more than
Read More
June 21, 2021
Establishment Labs Announces Publication of Landmark Breast Implant Surface Research in Nature Biomedical Engineering
Professor Robert Langer and a team of MIT scientists demonstrated that an optimal breast implant surface architecture leads to significantly lower levels of inflammatory foreign body response and to healthier tissue capsule formation. Establishment Labs to host webcast at 10am EST on Tuesday June
Read More
June 1, 2021
Establishment Labs Announces Appointments of Heather Brennan as Head of U.S. Commercial Operations and Neeta Toprani as General Counsel & Corporate Secretary
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jun. 1, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Heather Brennan has joined the company as Head of U.S.
Read More
May 25, 2021
Establishment Labs Announces Participation in the Jefferies Virtual Healthcare Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--May 25, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief
Read More
May 18, 2021
Establishment Labs Announces Pratip Dastidar Has Joined the Company as Head of Global Operations
SANTA BARBARA, Calif. --(BUSINESS WIRE)--May 18, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Pratip Dastidar has been appointed Head of Global
Read More
Displaying 1 - 10 of 23